| Nanoencryption™ Technology |
Facing the growing menace to your brands?Pharmaceutical brands are increasingly threatened by counterfeiting and illegal channel diversion. As the proportion of pharmaceutical sales going through Internet outlets continues to grow, the counterfeiter's criminal activities get even easier. The Center for Medicines in the Public Interest estimates that $35 billion in pharmaceutical revenue (6% of total worldwide sales) is being lost annually to counterfeit and diverted products. A conservative estimate of counterfeiting and illegal diversion alone for a typical $3 Billion blockbuster drug can total $180 Million. Even more damaging than lost sales is the liability exposure created when a blockbuster brand is illegally copied or diverted and the manufacturer can't or doesn't protect and authenticate it. And the most serious threat of all is the destruction of market share and company reputation inflicted by counterfeit and diverted products.Pharmaceutical companies can’t afford to ignore the urgent need for brand protection. In the interest of public safety, even the FDA and MHRA have major efforts in place to evaluate brand labeling and authentication programs. There is a deeply covert protective solution: Nanoencryption™ TechnologyNanoencryption technology is a layered pharmaceutical brand protection solution based on proprietary nanolithographic encryption technology. While overt techniques exist, and provide the advantage of easy field identification, overt technologies alone can’t protect your brand. If counterfeiters can see a label, they will defeat it. Nanoencryption technology incorporates semi-overt, covert, and nanoscale forensic features at the unit dose level which can also be linked to the package level for a multi-layered protective shield. Unfortunately, an authentic package does not certify authentic content. Counterfeiters and diverters routinely switch units and repackage them. A solid brand protection strategy demands authentication at the tablet level. Additionally, legitimate US drug distributors repackage products, which necessitates a unit level solution. Technologies like RFID, color shifting dyes and marking schemes work overtly or at the package level, but Nanoencryption technology is the only technology that provides deeply covert batch traceability at the unit level.Total, fully traceable securityNanoInk is the only company that provides a true forensic level track and trace brand protection at the unit level. Nanoencryption™ technology’s nanoscale cryptography can only be detected with highly specialized authentication tools located at centralized NanoInk centers. This stringent, molecular-scale lock-and-key model ensures complete brand security through all points in the supply chain. Authentication testing is done quickly (within 24-48 hours) in a completely non-destructive manner, providing forensic evidence.Nanoencryption technology on each tablet is directly linked to granular batch-specific data, including serial number, manufacture date, manufacture location and supply chain ship-to locations. The pharmaceutical company is in strict control of which Nanoencryption technology data points are coupled to each batch. Minimal manufacturing changesYou need to protect your brand integrity while continuing to run efficient and cost-effective production processes. That’s why Nanoencryption technology was designed around a trusted manufacturing technology familiar to every pharmaceutical company. Nanoencryption technology is new, but the underlying platform is time-tested, so NanoInk’s technology is easily inserted into the existing manufacturing environment. And with a strong intellectual property position that makes reverse engineering very difficult and extremely costly, Nanoencryption technology is a long-term solution. Finally, throughput is on par with your current processes.Our pharmaceutical clients completely control which encrypted data is used on each tablet. The Nanoencryption technology platform enables effortless changing of encryptions from batch to batch, putting process power exclusively in the hands of the manufacturer. Peace of mind at a minimal costConsidering the tens of millions of dollars in recovered profit Nanoencryption technology can drop to your company’s bottom line, not to mention the liability protection it offers, the investment is small. Because the manufacturing technology platform is already interwoven into most pharmaceutical operations, initial capital outlay is minimal. Nanoencryption technology does not chemically modify the dosage form, so regulatory barriers are very low and regulatory costs are nominal. In fact, the unsurpassed security provided by Nanoencryption technology costs only fractions of a cent per tablet, including encryption and authentication. By recapturing a meaningful portion of the revenue lost to counterfeit and diverted product, while lowering corporate liability and exposure, Nanoencryption technology can easily pay for itself in less than a year.Nanoink Inc 8025 Lamon Avenue Skokie, Illinois 60077 USA Phone: 1-847-679-NANO (6266) Fax: 1-847-679-8767 www.nanoink.net |